The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Biomarkers for epithelial-mesenchymal transitions
Open accessAbstract
Somatic cells that change from one mature phenotype to another exhibit the property of plasticity. It is increasingly clear that epithelial and endothelial cells enjoy some of this plasticity, which is easily demonstrated by studying the process of epithelial-mesenchymal transition (EMT). Published reports from the literature typically rely on ad hoc criteria for determining EMT events; consequently, there is some uncertainty as to whether the same process occurs under different experimental conditions. As we discuss in this Personal Perspective, we believe that context and various changes in plasticity biomarkers can help identify at least three types of EMT and that using a collection of criteria for EMT increases the likelihood that everyone is studying the same phenomenon - namely, the transition of epithelial and endothelial cells to a motile phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, proteins in the most significantly up-regulated network module (Extended Data Fig. 10d, 10f) included collagens (COL1A1 and COL3A1) and extracellular matrix glycoproteins (FN1, BGN, FBN1, and FBN2) that also are markers of EMT34, 35.”
From Proteogenomic characterization of human colon and rectal cancer (2014) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M. W., Reinhard, F., Zhang, C. C., Shipitsin, M. V., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,839
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Self-citationTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,947
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R., Côme, C., Savagner, P., Gitelman, I., Richardson, A. L., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,917
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew‐Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,852
Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
Yang, J., & Weinberg, R. A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,079
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20530 · Cited by 2,715
Self-citationTumour invasion and metastasis initiated by microRNA-10b in breast cancer
Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605
Research works printed but not linked: 8
- Kalluri, 2003, J. Clin. Invest., 112, 1776, 10.1172/JCI200320530 · DOI
- Xue, 2003, Cancer Res., 63, 3386
- Colwell, 2005, Adv. Biochem. Eng. Biotechnol., 93, 83
- Sommers, 1989, Cancer Res., 49, 4258
- Wernert, 2001, Anticancer Res., 21, 2259
- Higgins, 2007, J. Clin. Invest., 117, 3810
- Bates, 2005, J. Clin. Invest., 115, 339, 10.1172/JCI200523183 · DOI
- Gabbiani, 1981, Am. J. Pathol., 104, 206
Cited by
Sorted by citations
Items 801–900 of 1,004
Hypoxia-induced modulation of PTEN activity and EMT phenotypes in lung cancers
Kohnoh, T., Hashimoto, N., Ando, A., Sakamoto, K., Miyazaki, S., Aoyama, D., Kusunose, M., Kimura, M., Omote, N., Imaizumi, K., et al. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0308-3 · Cited by 38
“To determine whether persistent hypoxia can induce the acquisition of EMT phenotypes in H358 cells [6], western blotting analysis for fibronectin and E-cadherin was carried out [21–23], which demonstrated that hypoxia induced EMT phenotypes in H358 cells in a timedependent manner (Fig.”
MethodZhang, C., Wang, Y., Feng, Y., Zhang, Y., Ji, B., Wang, S., Sun, Y., Zhu, C., Zhang, D., & Sun, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.13348 · Cited by 38
“EMT (epithelial-to-mesenchymal transition), an essential cell biological program during embryonic development, contributes to cancer invasion and metastasis [13].”
BackgroundHutchins, E. J., & Bronner-Fraser, M. E. (2018) · Developmental Biology · doi:10.1016/j.ydbio.2018.12.021 · Cited by 38
“Given that Snail family members have been implicated in both EMT and the transcriptional control of laminin (Cano et al., 2000; Takkunen et al., 2008; Zeisberg and Neilson, 2009), we asked whether the effects of Draxin on laminin channel formation and basement membrane remodeling in cranial NC are mediated by Snail2.”
BackgroundRole of epithelial–mesenchymal transition factors in the histogenesis of uterine carcinomas
Franceschi, T., Durieux, E., Morel, A. P., Hilaire, P. D. S., Ray-Coquard, I. L., Puisieux, A., & Devouassoux‐Shisheboran, M. (2019) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-019-02532-w · Cited by 38
Han, I., Kim, J., Jang, K., & Ryu, J. (2019) · The Prostate · doi:10.1002/pros.23826 · Cited by 38
“of a mesenchymal phenotype by increasing mesenchymal markers, such as snail1, snail2, and α‐SMA.(65) Recently, several studies have indicated that EMT progression is regulated by activation of snail”
Hu, H., Dong, Z., Wang, X., Bai, L., Lei, Q., Yang, J., Li, L., Li, Q., Liu, L., Zhang, Y., et al. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s183558 · Cited by 38
“OncoTargets and Therapy 2019:12 submit your manuscript | www.dovepress.com DovePress 5169 DHC might inhibit cell migration/invasion via influencing the EMT.”
BackgroundInfluentialMicroRNA-532-3p Suppresses Malignant Behaviors of Tongue Squamous Cell Carcinoma via Regulating CCR7
Feng, C., So, H. I., Yin, S., Su, X., Xu, Q., Wang, S., Duan, W., Zhang, E., Sun, C., & Xu, Z. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00940 · Cited by 38
“EMT refers to the loss of carcinoma epithelial phenotype and the acquisition of mesenchymal-associated features (Zeisberg and Neilson, 2009).”
BackgroundZhang, Y., Liu, F., Zhang, C., Ren, M., Kuang, M., Xiao, T., Di, X., Feng, L., Fu, L., & Cheng, S. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.09.014 · Cited by 38
Butler, C., Sprowls, S. A., Szalai, G., Arsiwala, T. A., Saralkar, P. A., Straight, B., Hatcher, A. S., Tyree, E., Yost, M., Köhler, W., et al. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100775 · Cited by 40
“Since cytokeratin expression is decreased during the EMT process [27], we measured their expression profile using a pan-cytokeratin”
BackgroundMethodHasan, M. M., Viil, J., Lättekivi, F., Ord, J., Reshi, Q. U. A., Jääger, K., Velthut‐Meikas, A., Andronowska, A., Jaakma, Ü., Salumets, A., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155365 · Cited by 38
“Cytokeratins are present in abundance in epithelial cells, whereas vimentin is mostly found in fibroblasts [26].”
BackgroundHaider, M., Ridlmaier, N., Smit, D. J., & Taipaleenmäki, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062898 · Cited by 39
“Others have shown that several breast cancer cell lines over expressing IL-1ß demonstrated elevated EMT due to higher expression of N-cadherin and decreased levels of E-cadherin [50].”
BackgroundInfluentialZhong, M., Zhou, L., Fang, Z., Yao, Y., Zou, J., Xiong, J., Xiang, X., & Deng, J. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i26.4221 · Cited by 38
Ge, X., Peng, X., Li, M., Ji, F., Chen, J., & Zhang, D. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153580 · Cited by 40
Nasri, A., Foisset, F., Ahmed, E., Lahmar, Z. M., Vachier, I., Jørgensen, C., Assou, S., BOURDIN, A. A., & Vos, J. D. (2021) · Cells · doi:10.3390/cells10123467 · Cited by 41
Liu, J., Eischeid, A. N., & Chen, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051371 · Cited by 38
“to full transition to a mesenchymal phenotype [20].”
BackgroundInfluentialCiarrocchi, A., Piana, S., Valcavi, R., Gardini, G., & Casali, B. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.11.009 · Cited by 36
Wt1 and β-catenin cooperatively regulate diaphragm development in the mouse
Paris, N. D., Coles, G. L., & Ackerman, K. G. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2015.08.009 · Cited by 38
Salomon, A., Kéramidas, M., Maisin, C., & Thomas, M. (2015) · Oncotarget · doi:10.18632/oncotarget.3222 · Cited by 38
Adachi, T., Arito, M., Suematsu, N., Kamijo‐Ikemori, A., Omoteyama, K., Sato, T., Kurokawa, M. S., Okamoto, K., Kimura, K., Shibagaki, Y., et al. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.09.121 · Cited by 37
Guo, W.-T., Wang, X.-W., Yan, Y.-L., Li, Y., Yin, X., Zhang, Q., Melton, C. A., Shenoy, A., Reyes, N., Oakes, S. A., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.205 · Cited by 37
“Although only a few epithelial genes were downregulated, most mesenchymal genes, including key EMT regulators, such as Snai1, Twist1, and Zeb1, were significantly upregulated,(19,20,23,24) indicating an intermediate EMT process.(23) In addition, we confirmed that the protein levels of CDH1 (also known as E-Cadherin) a…”
Chun, H. W., & Hong, R. (2016) · Oncology Letters · doi:10.3892/ol.2016.4884 · Cited by 37
“A variety of transcription factors all interact with the E-box element within the proximal region of the E‑cadherin promoter, including the zinc finger Snail homologs Snail1, Snail2/Slug and Snail3, and several basic helix-loop-helix factors, such as Twist, ZEB-1 and ZEB-2 (32,34-36).”
Li, P., Sun, T., Yuan, Q.-Z., Pan, G., Zhang, J., & Sun, D.-W. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s113768 · Cited by 38
“One symbol of EMT is downregulation of E-cadherin acting as a cell–cell adhesion protein, resulting in instability of the adherens junctions that connect cells.(34) By undergoing this transition, epithelial cells gradually lose their epithelial markers, such as E-cadherin, laminin-1, and cytokeratin, and express the m…”
BackgroundMaterial Strategies for Modulating Epithelial to Mesenchymal Transitions
Mihalko, E. P., & Brown, A. C. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00751 · Cited by 38
Tyszka‐Czochara, M., Lasota, M., & Majka, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010266 · Cited by 37
“Many cell culture experiments and in vivo studies have demonstrated that inhibition of E-cadherin expression by its transcriptional suppressor SNAI1 is a key process driving EMT [22], also in cervical cancers [1].”
BackgroundWang, Y.-D., Sun, X., Yin, J., Yin, M., Wang, W., Nie, Z., & Xu, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.116 · Cited by 37
An Updated Review of Oral Cancer Stem Cells and Their Stemness Regulation
Shin, K.-H., & Kim, R. H. (2018) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2018027501 · Cited by 37
TGF-β inducible epithelial-to-mesenchymal transition in renal cell carcinoma
Tretbar, S., Krausbeck, P., Müller, A., Friedrich, M., Vaxevanis, C., Bukur, J., Jasinski‐Bergner, S., & Seliger, B. (2019) · Oncotarget · doi:10.18632/oncotarget.26682 · Cited by 37
Rajić, J., Inić‐Kanada, A., Stein, E., Dinić, S., Schuerer, N., Uskoković, A. S., Ghasemian, E., Mihailović, M., Vidaković, M., Grdović, N., et al. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00253 · Cited by 37
“Thus, decreased expression of E-cadherin, a cell–cell adhesion molecule that is highly expressed in epithelial cells, has become a hallmark of the EMT process (Zeisberg and Neilson, 2009).”
BackgroundCellular phenotypic transitions in diabetic nephropathy: An update
Cao, Y., Lin, J., Hammes, H., & Zhang, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1038073 · Cited by 38
“EMT has been classified into three distinct classes: Type I EMT is associated with embryogenesis and organ development; type II EMT is induced in the context of inflammation and fibrosis, and type III EMT is associated with cancer progression (Zeisberg and Neilson, 2009; Carew et al., 2012).”
BackgroundThe Role of MiR-29 in the Mechanism of Fibrosis
Wang, M., Huo, Z., He, X.-Y., Liu, F., Liang, J., Wu, L., & Yang, D. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557523666230328125031 · Cited by 36
Poursani, E. M., Mercatelli, D., Raninga, P. V., Bell, J. L., Saletta, F., Kohane, F. V., Neumann, D., Ye, Z., Rouaen, J. R. C., Jue, T. R., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01083-7 · Cited by 38
“d Radar plot contrasting average phenotypic signatures for all cells in each treatment condition (color coded as in a, c) across all [11] EM state marker intensities and [2] basic”
BackgroundMethodILEI: a novel marker for epithelial–mesenchymal transition and poor prognosis in colorectal cancer
Gao, Z., Lu, C., Wang, Z., Song, Y., Zhu, J., Gao, P., Sun, J., Chen, X., Wang, M., Dong, Y., et al. (2014) · Histopathology · doi:10.1111/his.12435 · Cited by 36
“Vimentin is considered a hallmark of mesenchymal-like conversion of epithelial cells, and appears to be one of the best indicators of EMT in carcinomas.(6,7) Accumulating evidence indicates that EMT plays an important role in cancer invasiveness and metastasis, possibly resulting in poor prognosis.”
BackgroundFBW7 Upregulation Enhances Cisplatin Cytotoxicity in Non-small Cell Lung Cancer Cells
Yu, H., Wei, W., Xia, L.-H., Han, W., Zhao, P., Wu, S., Li, W., & Chen, W. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.11.6321 · Cited by 36
Shin, S. Y., Kim, C. G., Jung, Y. J., Lim, Y., & Lee, Y. H. (2016) · Scientific Reports · doi:10.1038/srep34134 · Cited by 36
Chen, X., Peng, H., Xiao, J., Guan, A., Xie, B., He, B., & Chen, Q. (2017) · Oncology Reports · doi:10.3892/or.2017.5874 · Cited by 36
“Generally, N-cadherin and vimentin are considered to be mesenchymal markers (28-30) while E-cadherin is regarded as an epithelial marker (28,29,31).”
BackgroundBiology and clinical significance of circulating tumor cell subpopulations in lung cancer
O′Flaherty, L., Wikman, H., & Pantel, K. (2017) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.07.03 · Cited by 36
The role of the epithelial-to-mesenchymal transition (EMT) in diseases of the salivary glands
Sisto, M., Lisi, S., & Ribatti, D. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1680-y · Cited by 38
“The results of studies conducted since 2007 have suggested several characteristics for the classification of EMT: type 1 EMT affects embryo formation, gastrulation, neurulation, and neural crest formation (Thiery et al. 2009; Zeisberg and Neilson 2009; Kalluri and Weinberg 2009).”
BackgroundLi, D.-P., Fan, J., Wu, Y.-J., Xie, Y., Zha, J., & Zhou, X. (2017) · PubMed Central · Cited by 36
Tuning intermediate filament mechanics by variation of pH and ion charges
Schepers, A. V., Lorenz, C., & Köster, S. (2020) · Nanoscale · doi:10.1039/d0nr02778b · Cited by 36
Chen, H.-Y., Chiang, Y., Huang, J.-S., Huang, T., Shih, Y.-H., Wang, K.-L., Ali, M. K., Hong, Y.-H., Shieh, T., & Hsia, S. (2021) · Cancers · doi:10.3390/cancers13061236 · Cited by 36
“Other mesenchymal markers in EMT include vimentin, fibronectin and α-smooth muscle actin (α-SMA), which are also markers for myofibroblast [11].”
BackgroundJin, Q., Ren, Q., Chang, X., Yu, H., Jin, X., Lu, X., He, N., & Wang, G. (2021) · Journal of Cancer · doi:10.7150/jca.52851 · Cited by 36
Mohammed, S., Shamseddine, A. A., Newcomb, B., Chavez, R. S., Panzner, T. D., Lee, A. H., Canals, D., Okeoma, C. M., Clarke, C. J., & Hannun, Y. A. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01452-5 · Cited by 36
“In the EMT, cells lose epithelial characteristics and transition to display more mesenchymal features resulting in increased motility [54].”
BackgroundYoum, Y., Yang, H., Amin, R., Smith, S. R., Leff, T., & Dixit, V. D. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00574.x · Cited by 37
“The secondary mesenchymal cells generated through the process of EMT retain multipotency (Mani et al., 2008); however, the FSP1+, type 2 EMT cells (Zeisberg & Neilson, 2009) in aging thymus express PPARc and appear to be committed to adipocyte lineage (Youm et al., 2009).”
Aomatsu, K., Arao, T., Abe, K., Kodama, A., Sugioka, K., MATSUMOTO, K. Y., Kudo, K., Kimura, H., Fujita, Y., Hayashi, H., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8222 · Cited by 36
Hassan, S. S., Romero, R. J., Tarca, A. L., Nhan‐Chang, C., Mittal, P., Vaisbuch, E., Gonzalez, J., Chaiworapongsa, T., Ali‐Fehmi, R., Dong, Z., et al. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.06.076 · Cited by 36
Pancreatic cancer: disease dynamics, tumor biology and the role of the microenvironment
Ansari, D., Frieß, H., Bauden, M. P., Samnegård, J., & Andersson, R. E. (2018) · Oncotarget · doi:10.18632/oncotarget.24019 · Cited by 35
Chang, A. C. Y., Garside, V. C., Fournier, M., Smrz, J., Vrljicak, P., Umlandt, P., Fuller, M., Robertson, G., Zhao, Y., Tam, A., et al. (2014) · Developmental Dynamics · doi:10.1002/dvdy.24127 · Cited by 35
“Table S2) (Zeisberg and Neilson, 2009).”
Shanmuganathan, S., Lavanya, R., Brindha, P., & Angayarkanni, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120512 · Cited by 35
“EMT generates mesenchymal-like cells from epithelial cells, and it is characterized by up-regulation of mesenchymal markers like αSMA, MMPs, vimentin, N-Cadherin and down-regulation of epithelial markers like E-Cadherin, ZO-1, cytokeratin [25].”
BackgroundPerks, C. M., Zielinska, H., Holly, J. M. P., & Bahl, A. K. (2015) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s43932 · Cited by 35
“A defining feature of EMT is a loss of epithelial cell adhesion molecule E-cadherin and a gain of mesenchymal cell markers such as vimentin, N-cadherin, and fibronectin.(38) A number of studies have shown a strong correlation between the EMT and high invasive and metastatic behavior of breast cancer.”
Zhang, Y., Yan, W., Jung, Y.-S., & Chen, X. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.358143 · Cited by 35
“In this study, we found that knockdown of p73 or TAp73 disrupts cell polarity, accompanied by loss of E-cadherin, accumulation of -catenin in the nucleus, and increased expression of laminin V. Consistent with the notion that E-cadherin is repressed by Snail-1, Slug, and Twist (33, 45), we found that Snail-1, Slug, an…”
BackgroundInfluentialp120 catenin is a key effector of a Ras-PKCɛ oncogenic signaling axis
Dann, S. G., Golas, J., Miranda, M., Shi, C., Wu, J., Jin, G., Rosfjord, E. C., Upeslacis, E., & Klippel, A. (2013) · Oncogene · doi:10.1038/onc.2013.91 · Cited by 36
Lin, W., Zhuang, Q., Zheng, L., Cao, Z., Shen, A., Li, Q., Fu, C., Feng, J., & Peng, J. (2015) · Oncology Reports · doi:10.3892/or.2015.3784 · Cited by 35
the Papillophar Study Group, Lefèvre, M., Rousseau, A., Rayon, T., Dalstein, V., Clavel, C., Beby‐Defaux, A., Prétet, J., Soussan, P., Polette, M., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2016.434 · Cited by 35
“…largely used in the literature to identify tumour cells undergoing EMT with a fibroblastoid phenotype in carcinomas (Gabbiani et al , 1981; Klymkowsky and Savagner, 2009, Zeisberg and Neilsson, 2009 and particularly in OPC (Hatakeyama et al , 2014; Schrader et al , 2015; Wakasika et al , 2015).”
Zhang, D., Chen, B., Zhang, L., Cheng, M.-K., Fang, X., & Wu, X. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504017x14886494526344 · Cited by 35
Cao, Q., Liu, F., Li, C.-Z., Liu, N., Shu, M., Lin, Y., Ding, L., & Xue, L. (2018) · BMC Cancer · doi:10.1186/s12885-018-4000-y · Cited by 35
Liu, Z., Mi, C., Xie, L., Liu, T., Zou, Z., Li, Y., Chen, P., Peng, X., Ma, C., Zhang, W., et al. (2018) · Aging · doi:10.18632/aging.101571 · Cited by 35
“In HCC, E-cadherin, N-cadherin and vimentin are involved in various steps of metastasis, such as loss of cell-cell/cell-ECM adhesion, invasion of ECM, and angiogenesis [24, 25] .”
BackgroundIbrahim, D. G., Ko, J., Iwata, W., Okumichi, H., & Kiuchi, Y. (2019) · Cell Biochemistry and Function · doi:10.1002/cbf.3382 · Cited by 37
Jo, H., Lee, J., Jeon, J. Y., Kim, S. Y., Chung, J.-I., Ko, H. Y., Lee, M., & Yun, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-58124-1 · Cited by 37
Teoh, S. T., Ogrodzinski, M. P., & Lunt, S. Y. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.07.031 · Cited by 35
Genes involved in the epithelial-mesenchymal transition in oral cancer: A systematic review
Vallina, C., López‐Pintor, R. M., González‐Serrano, J., de Vicente, J. C., Hernández, G., & Lorz, C. (2021) · Oral Oncology · doi:10.1016/j.oraloncology.2021.105310 · Cited by 35
Jiang, M., Qi, Y., Huang, W., Lin, Y., & Li, B. (2022) · Cells · doi:10.3390/cells11213473 · Cited by 39
“This transition can impair the adhesion of epithelial cells and enhance motility [24].”
BackgroundNguyen, P. T., Kudo, Y., Yoshida, M., Iizuka, S., Ogawa, I., & Takata, T. (2010) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2010.00966.x · Cited by 35
Zhu, Z., Zhu, Z., Pang, Z., Xing, Y., Wan, F., Lan, D., & WANG, H. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1807 · Cited by 35
Zhang, J., Luo, N., Tian, Y., Li, J., Yang, X., Yin, H., Xiao, C., Sheng, J., Yang, L., Tang, B., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15798 · Cited by 35
The Prognostic Impact of TGF-β1, Fascin, NF-κB and PKC-ζ Expression in Soft Tissue Sarcomas
Valkov, A., Sørbye, S. W., Kilvaer, T. K., Dønnem, T., Smeland, E., Bremnes, R. M., & Busund, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017507 · Cited by 34
“Multiple molecular mediators of EMT have been described in carcinomas [15].”
BackgroundAndarawewa, K. L., Costes, S. V., Fernandez‐Garcia, I., Chou, W. S., Ravani, S. A., Park, H. E., & Barcellos‐Hoff, M. H. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.11.058 · Cited by 34
Chen, C.-H., Cheng, C.-Y., Chen, Y.-C., Sue, Y., Liu, C.-T., Cheng, T., Hsu, Y., & Chen, T.-H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099802 · Cited by 34
“It is characterized by the loss of epithelial characteristics (Ecadherin) and increased mesenchymal phenotype (alpha smooth muscle actin [a-SMA], Snail, and fibronectin) [10].”
BackgroundAn, J., Zheng, Y., & Dann, C. T. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.12.006 · Cited by 34
“CDH1 is one of the defining features of the epithelial state (Zeisberg and Neilson, 2009).”
BackgroundZeng, J., Cai, X., Hao, X., Huang, F., Zhihui, H., Sun, H., Lu, Y., Lei, J., Zeng, W., Liu, Y., et al. (2018) · International Journal of Hyperthermia · doi:10.1080/02656736.2017.1422030 · Cited by 34
“Vimentin was also not expressed in epithelial cells, but identified as an EMT marker in epithelial malignant tumours [43].”
BackgroundSu, Q., Sun, Y., Ye, Z., Yang, H., & Li, L. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.122 · Cited by 34
“In the process of EndMT, the expression levels of endothelial markers such as E-cadherin and PECAM1 are attenuated, whereas the expression levels of mesenchymal markers such as N-cadherin, fibronectin and Snail are acquired [7].”
BackgroundIdentification of LIMK2 as a therapeutic target in castration resistant prostate cancer
Nikhil, K., Chang, L., Viccaro, K., Jacobsen, M. H., McGuire, C., Satapathy, S. R., Tandiary, M. A., Broman, M. M., Cresswell, G. M., He, Y. J., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.035 · Cited by 34
Pierre, N., Salée, C., Massot, C., Blétard, N., Mazzucchelli, G., Smargiasso, N., Morsa, D., Baiwir, D., Pauw, E. D., Reenaers, C., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz130 · Cited by 36
Han, Y., Song, C., Zhang, T., Zhou, Q., Zhang, X., Wang, J., Xu, B., Zhang, X., Liu, X., & Ying, X. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1817666 · Cited by 35
“Downregulation of E-cadherin is thought to promote metastasis during early carcinogenesis progression [38] and has been reported to occur by many transcript factors such as Snail, WT1 and ZEB1/2 [19,39].”
BackgroundHu, Q., Chen, W., Yan, T., Ma, T., Chen, C.-L., Liang, C., Zhang, Q., Xia, X., Liu, H., Zhi, X., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.07.003 · Cited by 34
“The in vitro characterization of EMT is primarily based upon alterations in biomarker expression [34], including the absence of epithelial markers, increased expression of HSP47, collagen a1/a2, or vimentin, and other biological changes.”
BackgroundBonavida, B., & Baritaki, S. (2012) · Forum on Immunopathological Diseases and Therapeutics · doi:10.1615/forumimmundisther.2012006065 · Cited by 34
Busch, E. L., McGraw, K. A., & Sandler, R. S. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0017 · Cited by 34
“no studies of markers prominently discussed in the EMT literature (2, 4) were missed.”
BackgroundNOP14 promotes proliferation and metastasis of pancreatic cancer cells
Zhou, B., Wu, Q., Chen, G., Zhang, T., & Zhao, Y.-P. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.010 · Cited by 34
“E-cadherin and vimentin are specific EMT protein markers, contributes to cancer progression by increasing invasion, and/ormetastasis [23,24].”
BackgroundSvegliati‐Baroni, G., Faraci, G., Fabris, L., Saccomanno, S., Cadamuro, M., Pierantonelli, I., Trozzi, L., Bugianesi, E., Guido, M., Strazzabosco, M., et al. (2010) · Gut · doi:10.1136/gut.2010.219741 · Cited by 34
“The main findings of our study are that in CHC (1) IR and the degree of necroinflammation are independent predictors of advanced fibrosis; (2) IR and the degree of necroinflammation are significantly associated with expansion of the DR; (3) ductular reactive cells express phenotypic markers suggestive of EMT.”
BackgroundResultInfluentialLaskov, I., Abou-Nader, P., Amin, O., Philip, C., Beauchamp, M.-C., Yasmeen, A., & Gotlieb, W. H. (2016) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000761 · Cited by 34
“This EMT promotes the interaction of tumorcellswith the stroma, facilitating invasionandmetastasis.(9,10) Several transcription factors have emerged in recent years that trigger the down-regulation of E-cadherin and consequently promote EMT in different types of cancer.”
BackgroundJi, J., Jia, S., Jia, Y., Ji, K., Hargest, R., & Jiang, W. G. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.285 · Cited by 33
“At transcription and translation levels, WISP-2 knockdown in GC cells triggers an upregulation of Twist, N-cadherin and Vimentin, markers of mesenchymal genotype (Zeisberg and Neilson, 2009).”
BackgroundHan, B., Cui, D., Jing, Y., Hong, Y., & Xia, S. (2012) · World Journal of Urology · doi:10.1007/s00345-011-0819-4 · Cited by 33
Alipio, Z., Jones, N., Liao, W., Yang, J., Kulkarni, S. S., Kumar, K. S., Hauer‐Jensen, M., Ward, D. C., Ma, Y., & Fink, L. M. (2011) · Differentiation · doi:10.1016/j.diff.2011.05.001 · Cited by 33
“To further document that EMT is occurring in ATII-like cells, we analyzed gene expression of 52 EMT-related markers that were shown to be significantly upregulated during EMT by qRT-PCR (Kalluri and Neilson, 2003; Zeisberg and Neilson, 2009).”
BackgroundInfluentialTanaka, M. R., Kijima, H., Shimada, H., Makuuchi, H., Ozawa, S., & Inokuchi, S. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3966 · Cited by 33
“Vimentin is an important protein constituent of cellular intermediate filaments in normal and tumor mesenchymal cells (13,14).”
Gene-expression signatures in ovarian cancer: Promise and challenges for patient stratification
Konecny, G. E., Winterhoff, B. J. N., & Wang, C. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.01.026 · Cited by 33
“Importantly, this level of gene expression that is primarily derived from host cell infiltrates (immunoreactive and stromal) may be distinct from a tumor cell related epithelial-mesenchymal plasticity (differentiated and proliferative/mesenchymal) [49, 50].”
BackgroundS100A8+stroma cells predict a good prognosis and inhibit aggressiveness in colorectal carcinoma
Li, S., Xu, F., Li, H., Zhang, J., Zhong, A., Huang, B., & Lai, M. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1260213 · Cited by 33
“N-cadherin (N-CAD), along with activated transcription factors like SNAIL.(16) Cells that acquire an EMT phenotype are resistant to”
BackgroundSun, D., Luo, F., Xing, J., Zhang, F., Xu, J., & Zhang, Z. (2018) · Cell Proliferation · doi:10.1111/cpr.12461 · Cited by 33
Tang, L., Zhao, P., & Kong, D. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4691 · Cited by 33
“In general, the downregulation of E-cadherin and upregulation of Vimentin are considered as the hallmarks of EMT (17), along with a number of key transcription factors, such as Snail, Slug and ZEB, which have been shown to potentiate EMT progression (18).”
BackgroundDong, Y., Sun, Y., Huang, Y., Fang, X., Sun, P., Dwarakanath, B. S. R., Kong, L., & Lu, J. J. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.11.104 · Cited by 33
Parte, S. C., Nimmakayala, R. K., Batra, S. K., & Ponnusamy, M. P. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188669 · Cited by 33
Zheng, T., Chou, J., Zhang, F., Liu, Y., Ni, H., Li, X., Zheng, L., Tang, T., Jin, L., & Xi, T. (2015) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2015.05.010 · Cited by 33
Trachoma and Ocular Chlamydial Infection in the Era of Genomics
Derrick, T. R., Roberts, C. H., Last, A. R., Burr, S. E., & Holland, M. J. (2015) · Mediators of Inflammation · doi:10.1155/2015/791847 · Cited by 33
Neratinib shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo
Schwab, C. L., English, D. P.-G., Black, J., Bellone, S., Lopez, S., Cocco, E., Bonazzoli, E., Bussi, B., Predolini, F., Ferrari, F., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.08.002 · Cited by 33
“Some studies regarding the origins of carcinosarcoma suggest that it develops as a result of epithelial to mesenchymal transformation [6] [7].”
BackgroundRyu, H. S., Chung, J.-H., Lee, K., Shin, E., Jin, J., Choe, G., Kim, H., Xu, X., Lee, H. E., Kim, D. G., et al. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.07.004 · Cited by 33
“This process is involved in embryologic morphogenesis and fibrosis and, lately, has been implicated in tumor invasion and metastasis [2,3].”
BackgroundDetection and cultivation of circulating tumor cells in malignant pleural mesothelioma.
Bobek, V., Kacprzak, G., Rzechonek, A., & Kološtová, K. (2014) · PubMed · Cited by 33
Lawson, J., Liu, H.-H., Syme, H., Purcell, R., Wheeler-Jones, C., & Elliott, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202577 · Cited by 26
Prognostic value of ZEB-1 in solid tumors: a meta-analysis
Chen, B., Chen, B., Zhu, Z., Ye, W., Zeng, J., Liu, G., Wang, S., Gao, J., Xu, G., & Huang, Z. (2019) · BMC Cancer · doi:10.1186/s12885-019-5830-y · Cited by 33
“[4] Research demonstrated that ZEB-1 promotes the process of EMT through regulation of the relevant protein binding domains, such as the p300-P/CAF binding domain, Smad interaction domain, and C-terminal-binding protein interaction domain.”
BackgroundPitx3 directly regulates Foxe3 during early lens development
Ahmad, N., Aslam, M., Münster, D., Horsch, M., Khan, M. A., Carlsson, P., Beckers, J., & Graw, J. (2013) · The International Journal of Developmental Biology · doi:10.1387/ijdb.130193jg · Cited by 32
β-Cell Differentiation of Human Pancreatic Duct–Derived Cells After In Vitro Expansion
Corritore, E., Dugnani, E., Pasquale, V., Misawa, R., Witkowski, P., Lei, J., Markmann, J., Piemonti, L., Sokal, E. M., Bonner-Weir, S., et al. (2014) · Cellular Reprogramming · doi:10.1089/cell.2014.0025 · Cited by 31
“The HDDCs phenotype corresponded to a partial EMT, different from classical in vivo EMT models (Zeisberg and Neilson, 2009) because it appeared de novo in specific culture conditions.”
InfluentialSingh, N., Liu, G., & Chakrabarty, S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27902 · Cited by 32
“The expression of EMT associated transcription factors such as Snail1, Snail2, Twist and FOXC2 is up-regulated in invasive colon cancer and these transcription factors have been reported to play important roles in driving cancer progression and the EMT process.(40,41) Next, we determined the expression level of these…”
BackgroundIhara, Y., Inai, Y., & Ikezaki, M. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23176 · Cited by 32
Metadata
- Authors
- Zeisberg, M., & Neilson, E. G.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Vanderbilt University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2009-06-01
- Volume
- 119
- Issue
- 6
- Pages
- 1429-1437
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2689132
- OpenAlex
- W1996118868
- Cited by
- 2,299
- References
- 124
- Citations by year
- 2026: 50 · 2025: 79 · 2024: 127 · 2023: 113 · 2022: 146 · 2021: 148 · 2020: 180 · 2019: 163 · 2018: 170 · 2017: 189 · 2016: 153 · 2015: 162 · 2014: 162 · 2013: 149 · 2012: 109
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R03DK081687, R01DK046282, DK46282, K08DK074558, DK-081687, DK074558)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- epithelial-mesenchymal transition, cellular plasticity, epithelial cells, endothelial cells, cell motility
- MeSH terms
- Animals, Cell Differentiation, Epithelial Cells, Fibroblasts, Humans, Neoplasms, Biomarkers, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review